Containment, Contamination, Hormones and In-Vitro

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Containment

Contamination

Hormones

In-Vitro

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

NOVEMBER 29, 2021

Essentially, a biologic is a product that is produced from living organisms or that contains components of living organisms. They are often heat sensitive, membrane impermeable, subject to enzymatic degradation, and susceptible to microbial contamination (a factor which impacts manufacturing steps and quality considerations).

Development

Development Protein Production Hormones

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

MAY 4, 2021

Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Billion and Adjusted Diluted EPS (2) to a Range of $3.55 Now Anticipates Revenues of Approximately $26 Billion for BNT162b2, Reflecting 1.6 Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-April 2021. per share amounts). Reported Diluted EPS (1).

Vaccination

Vaccination Vaccine Production Sales

Clinical Research Informer

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

Stay Connected